First Choice Healthcare Solutions Assigns New Lead of Physical/Occupational Therapy Division Pharmaceutical Investing
Catalyst Pharmaceuticals Supports Rare Disease Day® and Joins Global Movement to Raise Important Awareness for Rare Diseases Pharmaceutical Investing
Epizyme Announces 2016 Fourth Quarter and Full-Year Results Conference Call Date and March Investor Conferences Biotech Investing
Helix BioPharma Corp. Announces Licence for Worldwide Right to Anti-CEACAM6 Antibody From the Government of Canada Pharmaceutical Investing
Pieris Signs 1st Partnership for Anemia Drug PRS-080, Granting Exclusive Option in Japan to ASKA Pharmaceutical Pharmaceutical Investing
Ritter Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Business Update Pharmaceutical Investing
